MedTrace Logo

Hyperglycemia in Neurosurgery

NCT05236751 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2023-09-28

No results posted yet for this study

Summary

Poor glycemic control is recognized as a risk factor for postoperative infection. For the neurosurgical patient, postoperative infection can lead to devastating complications such as meningitis, encephalitis and death. Neurosurgical patients often receive high doses of medications that increase blood glucose levels such as steroids, placing them at a potentially higher risk for postoperative infection. The purpose of this multisite observational study is to assess the impact of severe intraoperative hyperglycemia as a risk factor for postoperative infection in the neurosurgical patient.

Conditions

Sponsors & Collaborators

  • University of Roma La Sapienza

    collaborator OTHER

  • Burdenko Neurosurgery Institute

    collaborator OTHER

  • Boston Medical Center

    lead OTHER

Principal Investigators

  • Robert J Canelli, MD · Boston Medical Center

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-24
Primary Completion
2023-04-11
Completion
2023-05-13

Countries

  • United States
  • Italy
  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05236751 on ClinicalTrials.gov